Mycopathologia

, Volume 175, Issue 5–6, pp 489–495 | Cite as

Chromoblastomycosis in Mainland China: A Systematic Review on Clinical Characteristics

  • Sha Lu
  • Changming Lu
  • Junmin Zhang
  • Yongxuan Hu
  • Xiqing Li
  • Liyan Xi
Article

Abstract

Chromoblastomycosis is one of the most frequent chronic infections caused by melanized fungi. In order to evaluate the clinical characteristics of chromoblastomycosis in Mainland China, we performed an evidence-based review of published literature. PubMed and Chinese-language database of CNKI, VIP and Wanfang data during January 1990–August 2011 were searched. Epidemiology, clinical features, laboratory findings, therapy and prognosis were analyzed. Cladophialophora carrionii was the most common causative agent in the north of the Mainland China, and Fonsecaea monophora and F. pedrosoi were the most common agents in the southern part of the Mainland China. Infection commonly initiated after the etiologic agents gain entrance through puncture wounds and more common involved extremities of the males. Skin lesions were found in different sites, like the extremities, buttocks, trunk and face, and presented diversity morphology. There were about seven different clinical types found in Mainland China: plaque type, tumoral type, cicatricial type, verrucous type, pseudo-vacuole type, eczymatous type and mixed type of lesions. The success of treatment for chromoblastomycosis was related to the causative agent, the clinical form and severity of the lesions. Most of the patients could be treated successfully with the physical treatment, chemotherapy and/or combination therapy. The itraconazole, terbinafine or a combination of both were commonly medication for these mycosis patients. Physical methods were usually indicated to support chemotherapy with some severe forms and long-lasting cases. Photodynamic therapy has been extended from the oncological field to that of antimicrobial chemotherapy in these years. We applied it on some recalcitrant cases of chromoblastomycosis and found its good clinical response, and hopeful it could be a promising therapy in near future.

Keywords

Chromoblastomycosis Clinical characteristics Mainland China Treatment 

References

  1. 1.
    Yu RY, Gao L. Chromoblastomycosis successfully treated with fluconazole. Int J Dermatol. 1994;33:716–719.PubMedCrossRefGoogle Scholar
  2. 2.
    Yu R. Successful treatment of chromoblastomycosis with itraconazole. Mycoses. 1995;38:79–83.PubMedCrossRefGoogle Scholar
  3. 3.
    Xibao Z, Changxing L, Quan L, Yuqing H. Treatment of chromoblastomycosis with terbinafine: a report of four cases. J Dermatol Treat. 2005;16:121–124.CrossRefGoogle Scholar
  4. 4.
    Yang Y, Hu Y, Zhang J, Li X, Lu C, Liang Y, et al. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy. Med Mycol 2012.Google Scholar
  5. 5.
    Xi L, Lu C, Sun J, Li X, Liu H, Zhang J, et al. Chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora. Med Mycol. 2009;47:77–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Zhang JM, Xi LY, Zhang H, Xie Z, Sun JF, Li XQ, et al. Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora. Eur J Dermatol. 2009;19:451–455.PubMedGoogle Scholar
  7. 7.
    Zhang J, Xi L, Lu C, Li X, Xie T, Zhang H, et al. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong. China Mycoses. 2009;52:176–181.CrossRefGoogle Scholar
  8. 8.
    Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47:3–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Shankar J, Restrepo A, Clemons KV, Stevens DA. Hormones and the Resistance of Women to Paracoccidioidomycosis. Clin Microbiol Rev. 2011;24:296–313.PubMedCrossRefGoogle Scholar
  10. 10.
    Castro RM, Castro LGM. On the priority of description of chromomycosis. Mykosen. 1987;30:397–403.PubMedCrossRefGoogle Scholar
  11. 11.
    Rudolph M. über die brasilianische ‘Figueira’ (Vorläufige Mitteilung). Archiev Schiffs und Tropen-Hyg. 1914;18:498–499.Google Scholar
  12. 12.
    De Hoog GS, Attili-Angelis D, Vicente VA, Van Den Ende AH, Queiroz-Telles F. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol. 2004;42:405–416.PubMedCrossRefGoogle Scholar
  13. 13.
    Xi L, Sun J, Lu C, Liu H, Xie Z, Fukushima K, et al. Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China. Med Mycol. 2009;47:27–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Andrade TS, Castro LGM, Nunes RS, Gimenes VMF, Cury AE. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses. 2004;47:216–221.PubMedCrossRefGoogle Scholar
  15. 15.
    Klein A, Babilas P, Karrer S, Landthaler M, Szeimies R M. (2008) Photodynamic therapy in dermatology—an update 2008. J Dtsch Dermatol Ges 6:839–845, 839–846.Google Scholar
  16. 16.
    Lyon JP, Moreira LM, de Resende MA. Photodynamic Antifungal Therapy Against Chromoblastomycosis. Mycopathologia. 2011;172:293–297.PubMedCrossRefGoogle Scholar
  17. 17.
    Zhang RY, Cheng ZM. A case of Chromoblastomycosis. Chinese Journal of Diagnostic Pathology. 1995:241 (Chinese).Google Scholar
  18. 18.
    Nan GR, Wang GS, Si RL, Zhang GZ. A case of chromoblastomycosis cured with itraconazole. Chinese Journal of Dermatology. 1997:65 (Chinese).Google Scholar
  19. 19.
    Yan H. A case of Cutaneous Chromoblastomycosis. Chin J Clin Exp Pathol. 1997:76 (Chinese).Google Scholar
  20. 20.
    Li CY, Yan QD. Five case of chromoblastomycosis cured with itraconazole. J Clin Dermatol. 2000:352–353 (Chinese).Google Scholar
  21. 21.
    Li JL, Wang HW, Tang S. A case of chromoblastomycosis caused by Fonsecaea Compact. Chin J Dermatol. 2000:66 (Chinese).Google Scholar
  22. 22.
    Zhang XB, Huang JM. Misdiagnosis in one case with chromoblastomycosis. Chin J Dermatovenereol. 2000:63–64 (Chinese).Google Scholar
  23. 23.
    Yu CP, Wu M, Zhang FR. Treatment of chromoblastomycosis with itraconazole and local thermotherapy. Chin J Dermatovenereol. 2002:28–29 (Chinese).Google Scholar
  24. 24.
    Li CY, Shu Y, Guo SL. Clinical study in treatment of chromoblastomycosis with terbinafine. Chin J Dermatol. 2002:82 (Chinese).Google Scholar
  25. 25.
    Huang JM, Chen YF, Pan HQ. A case of chromoblastomycosis caused by Fonsecaea Pedrosoi. Southern China J Dermato-Venereol. 2002:40–41 (Chinese).Google Scholar
  26. 26.
    Li L, Xu HS, Wang JJ. A case of chromoblastomycosis with lymphatic spread. J Clin Dermatol. 2002:450–451 (Chinese).Google Scholar
  27. 27.
    Li M, Wu XF, Shen YN. Chromomycosis successful treated by surgical excision combined with terbenafine: report of a case. J Clin Dermatol. 2002:509–510 (Chinese).Google Scholar
  28. 28.
    Zhang QQ, Wei W, Wang JJ. A case of cutaneous chromoblastomycosis caused by Fonsecaea Pedrosoi. Chin J Dermatovenereol. 2002:50–51 (Chinese).Google Scholar
  29. 29.
    Zong WK, Zeng XS, Pan XF. Chromomycosis successful treated by surgical excision combined with Itraconazole: report of a case. Chin J Lepr Skin Dis. 2002:69–70 (Chinese).Google Scholar
  30. 30.
    Zhang YJ, Zhang GM, Zheng LX. Chromoblastomycosis caused by Fonsecaea Pedrosoi: the first case report in shenzhen and analysis. Chin J Dermatovenereol. 2003:50–52 (Chinese).Google Scholar
  31. 31.
    Gong YQ, Lu YW, Zhu HL. A case of Cutaneous Chromoblastomycosis Caused by Fonsecaea Pedrosoi. Southern Chin J Dermato-Venereol. 2008:299–300 (Chinese).Google Scholar
  32. 32.
    Wang J, Wu WX. A case of central nervous system invasion of chromoblastomycosis. J Hebei Med Univ. 1996:56 (Chinese).Google Scholar
  33. 33.
    Hui HY, Wang XL, Feng YG. A case of chromoblastomycosis Caused by Fonsecaea Pedrosoi. J Clin Dermatol. 2004:754 (Chinese).Google Scholar
  34. 34.
    Lu GL, Yao FL, Zhan QX. A case of Cutaneous Chromoblastomycosis. Chin J Dermatovenerol Integr Tradit and West Med. 2005:47 (Chinese).Google Scholar
  35. 35.
    Hui HY, Liu P, Wang XL. A case of pemphigus erythematosus patient with chromoblastomycosis. Chin J Dermatovenereol. 2005:301–302 (Chinese).Google Scholar
  36. 36.
    Qian LJ, Li L, Zhang QQ. A case of cutaneous chromoblastomycosis caused by Phialophora verrucosa. Chin J Dermatovenereol. 2005:556–557 (Chinese).Google Scholar
  37. 37.
    Pei ZH. A case of chromoblastomycosis cured by liquid nitrogen cryotherapy. Chin J Lepr Skin Dis. 2005:482–483 (Chinese).Google Scholar
  38. 38.
    Zhang TZ, Hu ZM, Kong Q Y. Treatment of chromoblastomycosis with terbinafine and local thermotherapy: a case report. J Clin Dermatol. 2006:403–404 (Chinese).Google Scholar
  39. 39.
    Xu XR, Li XQ, Xi LY. Chromomycosis caused by Fonsecaea pedrosoi. J Clin Dermatol. 2006:696–697 (Chinese).Google Scholar
  40. 40.
    Liu XW, Xu LC, Wang ZB. A case of cutaneous chromoblastomycosis. J Dermatol Venereol. 2006:55–56 (Chinese).Google Scholar
  41. 41.
    Liu GY, Jiang LY, Jin H. A case of Chromoblastomycosis. Chin J Lepr Skin Diseas. 2007:898–900 (Chinese).Google Scholar
  42. 42.
    Cha JD, Liu DX, Li SQ. A case of chromoblastomycosis cured combined with potassium iodide and itraconazole. Herald Med. 2007:270 (Chinese).Google Scholar
  43. 43.
    Liao J, Wu CH, Wu ZH. A case of chromoblastomycosis cased by Fonsecaea Pedrosoi misdiagnosed as tuberculosis verrucosa cutis. Southern Chin J Dermato-Venereol. 2008:38–40 (Chinese).Google Scholar
  44. 44.
    Jin XJ, Wang AP, Chen W. A case of chromoblastomycosis cured with itraconazole. Chin J Mycol. 2008:76–77 (Chinese).Google Scholar
  45. 45.
    Lv GX, Chen XJ, Shen YN. A case of Cutaneous Chromoblastomycosis Caused by Fonsecaea monophora. Chin J Mycol. 2009:155–157 (185) (Chinese).Google Scholar
  46. 46.
    Ou YG, Lin Y, Li HY. A Case of Chromoblastomycosis Misdiagnosed as Tuberculosis Cutis. Chin J Dermatovenereol. 2009:601–602 (Chinese).Google Scholar
  47. 47.
    Lu Y, He W, Weng X. Treatment of chromoblastomycosis with itraconazole and local thermotherapy: a case report. Chin J Dermatovenereol. 2009:454–455 (Chinese).Google Scholar
  48. 48.
    Li GZ, Liu YH, Li JJ. A case of cutaneous chromoblastomycosis. Chin J Dermatovenereol. 2010:878–879 (Chinese).Google Scholar
  49. 49.
    Liu HF, Xue RZ, Huang JM. Clinical analysis of chromoblastomycosis and identification of Fonsecaea monophora. China Tropical Medicine. 2010:1062–1064 (Chinese).Google Scholar
  50. 50.
    Chen HH, Li WQ, Huang W. A case of chromoblastomycosis with lymphatic spread. J Diagnos and Therap Dermato-venereol. 2010:373–374 (Chinese).Google Scholar
  51. 51.
    Jiang Q, Jin Y, Li ZH. A case of chromoblastomycosis caused by Fonsecaea Pedrosoi. Chin J Dermatovenereol. 2010:65–66 (Chinese).Google Scholar
  52. 52.
    Zhao ZT, Lu QY, Gao N. Chromoblastomycosis caused by Fonsecaea monophora in North China: first case report and. Chin J Mycol. 2010:193–195 (Chinese).Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Sha Lu
    • 1
  • Changming Lu
    • 1
  • Junmin Zhang
    • 1
  • Yongxuan Hu
    • 1
  • Xiqing Li
    • 1
  • Liyan Xi
    • 1
  1. 1.Department of Dermatology, Sun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhouChina

Personalised recommendations